IN8bio's total assets for Q3 2024 were $15.97M, a decrease of -29.03% from the previous quarter. INAB total liabilities were $7.38M for the fiscal quarter, a -16.87% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.